1. Home
  2. ONEW vs NERV Comparison

ONEW vs NERV Comparison

Compare ONEW & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$12.91

Market Cap

174.4M

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.28

Market Cap

189.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
NERV
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.4M
189.1M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
ONEW
NERV
Price
$12.91
$4.28
Analyst Decision
Buy
Hold
Analyst Count
4
1
Target Price
$16.75
$4.00
AVG Volume (30 Days)
183.0K
75.4K
Earning Date
01-29-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,872,334,000.00
N/A
Revenue This Year
$2.23
N/A
Revenue Next Year
$3.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.63
N/A
52 Week Low
$10.14
$1.15
52 Week High
$21.00
$12.46

Technical Indicators

Market Signals
Indicator
ONEW
NERV
Relative Strength Index (RSI) 50.29 52.76
Support Level $13.18 $3.75
Resistance Level $15.25 $4.49
Average True Range (ATR) 0.81 0.36
MACD -0.04 -0.02
Stochastic Oscillator 9.46 53.00

Price Performance

Historical Comparison
ONEW
NERV

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: